Re:Startups that demoed at Y Combinator W16 Demo Day 2
by danieltillett on Thursday March 24, 2016 @04:47AM
(#11351383)
Yes the bar in this area is very high as there are so many things that can go wrong.
I think the difference is with pure software you are just dealing with human created complexity - with biotech you also have nature’s complexity to deal with too. Mix the two together and spice it up with some unbelievably stringent regulations and you have a recipe for a lot of heartburn.
Ten years later I made another medical device investment. Again, good IP protection, FDA approved, clear data showing life-saving benefits. This one failed because the technical founders decided to go off the ranch and have a turf battle with the CEO.
The Murphy factor in this sector seems pretty high to me.